Please login to the form below

Not currently logged in
Email:
Password:

Aprecia

This page shows the latest Aprecia news and features for those working in and with pharma, biotech and healthcare.

3D printed epilepsy drug launched in the US

3D printed epilepsy drug launched in the US

Aprecia’s Spritam is now available as a prescription drug. The first ever drug manufactured using 3D printing technology is now available to US patients with epilepsy. ... Aprecia Pharmaceutical's Spritam was approved by the FDA in August last year,

Latest news

  • Printable pharma Printable pharma

    Spritam is designed to fill a need for patients who struggle with their current medication experience,” commented Don Wetherhold, Aprecia's chief executive. ... This is the first in a line of central nervous system products Aprecia plans to introduce

  • FDA approves world’s first 3D printed drug FDA approves world’s first 3D printed drug

    The drug Spritam (levetiracetam), from Aprecia Pharmaceuticals, has been given the green light from the US regulator as an adjunctive therapy in the treatment of partial onset seizures, myoclonic seizures and ... experience. "This is the first in a line

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics